 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Spandana Sphoorty's (Spandana) Q3FY21 performance was characterised by aggressive write-offs to the tune of ~Rs2bn (>120-dpd) and clear focus on pursuing growth but in calibrated manner, as reflected in 14% YTD-FY21 growth in AuM. Further, a provision buffer of ~Rs3.6bn (~5% of AuM) against a non-paying customer pool of ~2.2% and proforma NNPL at 1% would cushion earnings in coming quarters. Collection efficiency (ex-arrears) improved steadily to ~93% in Q3FY21 from ~89% in Q2FY21. While the company's PAR 60+ portfolio of 5.7% poses risk to asset quality, we believe Spandana will navigate through the current cycle relatively better than peers on the back of: 1) its diversified operations with ~80% of districts having <0.5% exposure per district; 2) provisioning buffer at Rs3.6bn (~5% of AuM); and 3) healthy capital position (CAR 39%). Maintain BUY with a target price of Rs900.
- Aggressive write/offs and muted revenue impacted earnings. NII fell 15% QoQ largely due to higher interest expense due to negative carry on higher liquidity and higher fee-related NCD issuance. Further, ~120bps reduction in lending yields during 9MFY21 and derecognising of Rs0.16bn interest income kept revenues lower. However, on a positive note, taking cognisance of improved collection, the company remained committed to grow its AuM, but in a calibrated manner. AuM has grown by 14% YTD-FY21 driven primarily by higher ticket size (up 15% YTD-FY21) while the borrowing base remained flat at ~Rs2.5mn during 9MFY21. Following an aggressive write-off policy, Spandana has written-off loans crossing 120-dpd worth ~Rs2bn, wiping out PPoP of Rs1.6bn and the company reporting loss of Rs297mn.
- Collections continue to trend well at ~93% (ex arrears) in Q3FY21. Spandana's collection efficiency at 93% (ex-arrears) in Q3FY21 is one of the highest in MFI space. Collections in states like Maharashtra, Odisha and Chhattisgarh remained lower than the average due to extended lockdown and a few instances of political interference. Customer activation remains strong as reflected in the non-paying borrowers pool falling to ~2.2% in Dec'20 from ~5.6% in Sep'20. Proforma GNPL stands at 2.7% excluding write-offs of ~Rs2bn while proforma NNPL stands at 1%. Considering the company carries a total provisioning buffer of ~Rs3.6bn or 5% of AuM, it expects credit cost to normalise from Q4FY21 onwards. Further, strong PPoP margin at an average of 14% over past five quarters and adequate capital would ensure Spandana navigates through the current challenging cycle relatively better than peers.
- Outlook. While we cut our FY21E/FY22E earnings estimates by ~45%/11% respectively to factor-in higher credit cost and sharp yield compression, we believe Spandana's comfortable capital position (CAR at 39%), industry-leading profitability (PPoP margin at average 14%) and ~500bps of provisioning buffer would ensure it achieves normalcy quicker than peers. Current valuation, at 1.6x / 1.4x FY22E / FY23E P/BV respectively, captures near-term asset quality risk. Maintain BUY with a target price of Rs900, valuing the stock at 1.6x FY23E BVPS. Key risks - A) stress unfolding higher than anticipation and B) lower AUM growth.